The Rehabilitation Engineering and Assistive Technology Society of North America (RESNA) has reportedly received a grant from the US Department of Labor (DOL) to establish the Office of Disability Employment Policy’s Accessible Technology Action Center.
Biopharmceutical company Neuralstem, Inc recently received approval to begin its clinical trial to treat motor deficits as a result of ischemic stroke with its spinal cord stem cells (NSI-566) at BaYi Brain Hospital, Beijing, China, according to a news release.
According to a new study conducted by Brigham and Women’s Hospital (BWH), researchers have pinpointed an approach that may help categorize multiple sclerosis (MS) into two meaningful subsets and potentially assist in treatment development.
StemCells Inc reports that it has now enrolled the first patient with an incomplete spinal cord injury (SCI) in its PhaseI/II clinical trial in chronic SCI and has administered its proprietary HuCNS-SC neural stem cells to the patient.
As a nod to the September National Preparedness Month, the Rocky Mountain ADA Center has released key tips designed to ensure emergency preparedness for individuals with disabilities.
A new bilingual booklet about sports injuries is available to readers through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH).
The American Occupational Therapy Association (AOTA) reports that its annual Hill Day saw more than 500 occupational therapy clinicians, educators, and students from across the nation convene on Capitol Hill September 24 to discuss key legislative is
A new agreement reached between Tuba City Regional Health Care and Mayo Clinic in Arizona, will provide residents of the city reported to be the largest in the Navajo Nation in need of emergency medical care for stroke, access to a Mayo Clinic telestroke program, according to a recent news release.
In a recent news release, a team of material engineers at Harvard led by Zhigang Suo, PhD, professor, report that they have developed a stretchy, robust, biocompatible, and self-healing hydrogel that may become a potential cartilage repair treatment option for human joint defects, such as osteoarthritis (OA).
A new study conducted by Kings College London has reportedly pinpointed a new gene that may play a key role in facilitating lower back pain.